Shipping update: 2022 CodeMap Manuals beginning shipping 1/19. All orders will be shipped by January 31.
CodeMap® Compliance Briefing: 2/25/2011
Each week, we receive many email inquiries from our subscribers concerning coding, reimbursement, coverage, and compliance issues associated with the Medicare and Medicaid programs. In recent months, one of the most frequent requests has been for clarification of the procedure codes providers must use to report drug screening procedures performed for beneficiaries of federally funded programs. Considering the number of changes CMS has made in the past two years concerning these codes, the number of inquiries concerning this issue is not surprising.
In addition, just this week, CMS published a MLN Matters Article (SE1105) concerning the codes used to report qualitative drug screens. In hopes of clearing up the significant confusion surrounding this topic, today's CodeMap® Compliance Briefing will once again attempt to explain the proper use of these procedure codes. As always, please feel free to email any questions, comments, or concerns to the author of this briefing.
Sorry, the full document you are trying to access requires an active subscription.
Please login to the left.